
|Articles|November 7, 2007
BIO issues white paper on comparative effectiveness
In a new paper, the Biotechnology Industry Organization reveals it has reservations about the use of comparative effectiveness in reviewing products.
Advertisement
The Biotechnology Industry Organization has issued a white paper on comparative effectiveness. Authored by BIO's director of economic policy Ted Buckley, Ph.D., the document maintains that while comparative effectiveness is a helpful tool for healthcare decision-makers when comparing different products, it cannot be used to provide one-size-fits-all answers. The report can be found on
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
TrumpRx Officially Launches, Introduces Drug Prices
2
President Trump Signs Sweeping, Unprecedented Federal PBM Reform
3
Q&A: PBMs, Community Pharmacy’s Next Move Following PBM Reform Signing
4
As Immunization Schedules Change, Vaccine Confidence Among Patients Falters
5























